Two studies show how immunotherapies together activate immune responses in melanoma

Two studies published in the latest issue of the journal cell Researchers at the University of Pittsburgh have discovered how immunotherapies that target the immune checkpoints PD1 and LAG3 work together to activate immune responses. The findings shed light on…